For the suppression of SULT1E1, it was also reported that cholestasis-induced farnesoid X receptor activation can lead to a reduction in SULT1E1 in cirrhotic liver tissues and, therefore, impede hepatic deactivation of estrogens in PBC [51]. This evidence concerns the gene NR1H4 and primary biliary cholangitis.